G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 118 filers reported holding G1 THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,969 | -90.0% | 10,395 | -81.5% | 0.00% | – |
| Q1 2023 | $150,187 | -79.1% | 56,040 | -57.6% | 0.00% | – |
| Q4 2022 | $717,434 | -29.6% | 132,124 | +61.9% | 0.00% | – |
| Q3 2022 | $1,019,000 | +786.1% | 81,628 | +251.2% | 0.00% | – |
| Q2 2022 | $115,000 | -84.5% | 23,245 | -76.2% | 0.00% | – |
| Q1 2022 | $741,000 | -19.3% | 97,635 | +8.7% | 0.00% | – |
| Q4 2021 | $918,000 | -55.2% | 89,857 | -41.2% | 0.00% | – |
| Q3 2021 | $2,049,000 | -49.8% | 152,737 | -17.9% | 0.00% | -100.0% |
| Q2 2021 | $4,082,000 | -43.1% | 186,051 | -37.7% | 0.00% | -75.0% |
| Q1 2021 | $7,180,000 | +225.3% | 298,451 | +143.2% | 0.00% | – |
| Q4 2020 | $2,207,000 | +471.8% | 122,695 | +268.2% | 0.00% | – |
| Q3 2020 | $386,000 | +22.5% | 33,326 | +140.7% | 0.00% | -100.0% |
| Q3 2019 | $315,000 | -57.9% | 13,847 | -3.2% | 0.00% | 0.0% |
| Q3 2018 | $748,000 | – | 14,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 856,798 | $6,512,000 | 1.75% |
| CHI Advisors LLC | 488,635 | $3,714,000 | 1.58% |
| Pinz Capital Management, LP | 186,515 | $1,418,000 | 0.88% |
| Lombard Odier Asset Management (Switzerland) SA | 542,183 | $4,121,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 316,137 | $2,403,000 | 0.24% |
| Birchview Capital, LP | 40,000 | $304,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 160,000 | $1,216,000 | 0.18% |
| Tekla Capital Management LLC | 423,869 | $3,221,000 | 0.11% |
| Golden Green, Inc. | 12,152 | $92,000 | 0.08% |
| Virtus ETF Advisers LLC | 15,188 | $115,000 | 0.05% |